Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,799 total articles
Descartes Systems Group announced that K&R International Services is utilizing Descartes' global security filing solution to automate the processing of European Union Import Control System 2 (ICS2) filings for large volumes of ecommerce shipments transported by charter cargo carriers. The automation improves efficiency, accuracy, and compliance for…
Nova Minerals Corp's CEO participated in a U.S. Department of Energy roundtable to discuss progress on establishing an integrated domestic supply chain for antimony, including military-grade antimony trisulfide from the Estelle project in Alaska. Supported by a $43.4 million Department of War award, the company is advancing mining, processing, and …
Gilat Satellite Networks Ltd. announced a $100 million private placement of five-year convertible notes with a 60% conversion premium, providing long-term financial flexibility to accelerate investments in next-generation satellite, space technologies, and expansion of its technology portfolio. The notes bear 3.75% interest and are targeted to supp…
Nano Labs Ltd, a Nasdaq-listed Web 3.0 infrastructure and crypto treasury company, announced the resignation of director Nan Hu effective August 31, 2026. The company stated the departure will not impact ongoing operations or strategic implementation. Nano Labs remains focused on advancing its strategic priorities and sustaining effective corporate…
FirstCash Holdings, Inc. has amended its unsecured revolving credit facility, increasing the committed amount from $700 million to $1.055 billion and extending the maturity from August 2029 to August 2031. The amendment also includes increased leverage capacity and flexibility in borrowing currencies. This extended facility supports FirstCash's gro…
Healthy Choice Wellness Corp. announced that Host Digital Infrastructure LLC has secured a 15-year, 43 MW take-or-pay lease valued at $1.25 billion at its northeast Oklahoma AI data center facility, with potential contract value up to $3.2 billion if renewal options are exercised. This lease underpins Host Digital's upcoming public market debut fol…
KBR has been awarded the front-end engineering design contract for the Live Oak consortium's large-scale electric natural gas (e-NG) project in Norfolk, Nebraska. The project, involving international partners including TotalEnergies and Japanese companies, aims to produce e-NG through renewable hydrogen and biogenic CO2, contributing to the US ener…
Alvotech announced that the U.S. FDA has accepted for review its Biologics License Application (BLA) for AVT80, a proposed interchangeable biosimilar to Entyvio delivered via prefilled syringe and autoinjector for subcutaneous administration. This complements AVT16, the intravenous biosimilar whose BLA was accepted in May 2026. Under a partnership …
WEBUY GLOBAL LTD. announced record preliminary unaudited travel bookings totaling approximately US$4.76 million during the three-day NATAS Fair in August 2026, marking a 42% increase from the previous fair in March 2026. Growth was driven by strong demand in both mainstream and premium travel offerings, supported by AI-assisted sales tools and stra…
WeRide, a global autonomous driving technology leader, has been included in the HKEX Tech 100 Index following the latest quarterly review. This inclusion reflects WeRide’s strength in innovation and commercialization within the Physical AI sector. Operating a large autonomous fleet across 13 countries, WeRide reported significant revenue growth and…
Octave Intelligence plc announced a strategic technology partnership with MAIRE to deploy AI solutions throughout engineering, procurement, and construction workflows. Building on over two decades of collaboration, the partnership integrates AI into existing workflows to improve data integrity, decision-making, and operational efficiency in complex…
AkzoNobel and Axalta revealed the appointment of Stephan B. Tanda, Denise C. Johnson, and Robert Schuchna as non-executive directors on the Board of the newly combined company after their pending merger. This expanded Board is intended to strengthen strategic oversight and accelerate growth and innovation post-merger, combining complementary portfo…
LexinFintech Holdings Ltd. announced Q2 2026 financial results showing revenue decline and an 80% drop in net income year-over-year, as sector-wide funding tightening affected loan volumes. The company maintained a strong user base growth and increased e-commerce platform GMV. Management emphasized disciplined cost and risk management, dividend pol…
BridgeBio Pharma announced compelling new data from the Phase 3 ATTRibute-CM study highlighting Acoramidis' ability to potentially reverse cardiac structural disease progression and functional decline in transthyretin amyloid cardiomyopathy (ATTR-CM). Treated patients experienced significant improvements in left ventricular function and substantial…
Cytokinetics announced additional positive results from two Phase 3 clinical trials, ACACIA-HCM and MAPLE-HCM, demonstrating that their drug aficamten improved cardiac function and symptoms in patients with non-obstructive and obstructive hypertrophic cardiomyopathy (HCM). Notably, ACACIA-HCM showed aficamten improved cardiac structure and diastoli…
Tenax Therapeutics announced additional data from its Phase 3 LEVEL trial evaluating oral levosimendan (TNX-103) in patients with pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF). While primary endpoints on exercise capacity were not met, subgroup analysis revealed significant improvements in patients with low…
20/20 BioLabs announced a rescheduled investor webinar to discuss its second quarter 2026 performance, highlighting record revenue growth from its multi-cancer early detection test, OneTest™. CEO Jonathan Cohen will detail the company's evolving test platform, successful state-funded cancer screening initiatives, and the strategic path toward regul…
Trinity Biotech plc provided an update on its diagnostics business highlighting commercial progress, advancement in manufacturing through outsourcing, expansion of its PrePsia patent portfolio, and ongoing transformation efforts aimed at profitable growth. The company also disclosed that it has not regained Nasdaq's minimum market value compliance …
AiRWA Inc. announced receiving a deficiency notice from Nasdaq owing to its failure to timely file the annual Form 10-K report for the fiscal year ended April 30, 2026. The delay is attributed to challenges in consolidating financials after a significant acquisition. The company has until October 23, 2026, to submit a compliance plan and expects to…
B2Gold Corp. announced a fatality at its Masbate Gold Project in the Philippines due to a pipe burst during maintenance at the Water Treatment Plant. The company has secured the incident area, halted related work, and is conducting an investigation. Mining and processing continue without interruption.
Arq, Inc., a NASDAQ-listed environmental technology company specializing in activated carbon products, has appointed Peter Owino as Chief Accounting Officer effective September 1, 2026. Owino, with over two decades of expertise in accounting and finance, has been serving in an interim capacity since June. The company granted him inducement equity a…
Norwood Financial Corp announced that its Board of Directors has adopted a stock repurchase program allowing the Company to buy back up to 550,000 shares, equivalent to about 5% of its outstanding common stock. This program replaces the prior repurchase plan authorized in 2021 and allows purchases via open market, private transactions, or trading p…
Hudbay Minerals Inc. filed an early warning report disclosing its decreased ownership in Panoro Minerals Ltd. from approximately 10.01% to 9.97% owing to an increase in Panoro's outstanding shares. Despite this dilution, Hudbay retains pre-emptive anti-dilution rights for maintaining at least 5% ownership. The filing complies with Canadian securiti…
Oragenics reports advancement of its Phase IIa clinical trial for its lead intranasal therapeutic candidate ONP-002 targeting mild traumatic brain injury (concussion). The company has dosed nine participants across three Australian sites and is preparing a U.S. IND application following FDA feedback. However, Oragenics received a NYSE American defi…
Crown Castle International Corp. is scheduled to present at the Bank of America 2026 Media, Communications & Entertainment Conference, highlighting its ongoing engagement with investors and industry stakeholders in the telecommunications infrastructure sector.
